186 related articles for article (PubMed ID: 17498084)
1. Achievement of immune tolerance in a patient with haemophilia B and inhibitory antibodies, complicated by an anaphylactoid reaction.
Curry NS; Misbah SA; Giangrande PL; Keeling DM
Haemophilia; 2007 May; 13(3):328-30. PubMed ID: 17498084
[TBL] [Abstract][Full Text] [Related]
2. Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX.
Barnes C; Davis A; Furmedge J; Egan B; Donnan L; Monagle P
Haemophilia; 2010 Sep; 16(5):840-1. PubMed ID: 20546030
[No Abstract] [Full Text] [Related]
3. Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).
Chitlur M; Warrier I; Rajpurkar M; Lusher JM
Haemophilia; 2009 Sep; 15(5):1027-31. PubMed ID: 19515028
[TBL] [Abstract][Full Text] [Related]
4. Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors, and history of anaphylaxis.
Alexander S; Hopewell S; Hunter S; Chouksey A
J Pediatr Hematol Oncol; 2008 Jan; 30(1):93-5. PubMed ID: 18176193
[TBL] [Abstract][Full Text] [Related]
5. Development of anaphylactic shock in haemophilia B patients with inhibitors.
Warrier I; Lusher JM
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S125-8. PubMed ID: 9819043
[TBL] [Abstract][Full Text] [Related]
6. Anaphylactoid reactions and nephrotic syndrome--a considerable risk during factor IX treatment in patients with haemophilia B and inhibitors: a report on the outcome in two brothers.
Tengborn L; Hansson S; Fasth A; Lübeck PO; Berg A; Ljung R
Haemophilia; 1998 Nov; 4(6):854-9. PubMed ID: 10028310
[TBL] [Abstract][Full Text] [Related]
7. Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure.
Barnes C; Rudzki Z; Ekert H
Haemophilia; 2000 Nov; 6(6):693-5. PubMed ID: 11122398
[TBL] [Abstract][Full Text] [Related]
8. Successful induction of immune tolerance with FIX recombinant in a patient with haemophilia B with inhibitor.
Soto I; Vicente JM; Corte JR; Urgellés MF; Pinto CR
Haemophilia; 2004 Jul; 10(4):401-4. PubMed ID: 15230957
[TBL] [Abstract][Full Text] [Related]
9. Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate.
Parquet A; Laurian Y; Rothschild C; Navarro R; Guérois C; Gay V; Durin A; Peynet J; Sultan Y
Thromb Haemost; 1999 Oct; 82(4):1247-9. PubMed ID: 10544907
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
Mathias M; Khair K; Hann I; Liesner R
Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for adolescents with haemophilia and high titre inhibitors.
Fox RA; Neufeld EJ; Bennett CM
Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
[TBL] [Abstract][Full Text] [Related]
12. [Factor IX inhibitor in hemophilia B presented with anaphylactoid symptoms: report of 3 cases].
Taketani T; Hanada R; Kawaguchi H; Ida K; Yamamoto K
Rinsho Ketsueki; 1999 Oct; 40(10):1124-6. PubMed ID: 10565232
[TBL] [Abstract][Full Text] [Related]
13. Immune tolerance induction for a patient with factor IX inhibitors--a case report.
Nagel K; Laudenbach L; Rivard GE; Jardine L; Chan AK; Pai MK
Haemophilia; 2011 Mar; 17(2):315. PubMed ID: 20825499
[No Abstract] [Full Text] [Related]
14. Successful induction of immune tolerance in a patient with haemophilia B with inhibitor.
Suzuki N; Watanabe J; Kudoh T; Hori T; Hatakeyama N; Mizue N; Oda T; Tsutsumi H
Haemophilia; 2003 May; 9(3):340-2. PubMed ID: 12694528
[TBL] [Abstract][Full Text] [Related]
15. Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.
Berntorp E; Astermark J; Carlborg E
Haematologica; 2000 Oct; 85(10 Suppl):48-50; discussion 50-1. PubMed ID: 11187871
[TBL] [Abstract][Full Text] [Related]
16. Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure: progress report.
Barnes C; Brewin T; Ekert H
Haemophilia; 2001 Jul; 7(4):439-40. PubMed ID: 11442653
[No Abstract] [Full Text] [Related]
17. The maintenance of tolerance after successful immune tolerance induction in hemophilia A and B: the North American Registry. Factor VIII/IX Subcommittee of the International Society for Thrombosis and Hemostasis.
DiMichele D; Kroner B;
Haematologica; 2000 Oct; 85(10 Suppl):40-2; discussion 42-4. PubMed ID: 11187869
[TBL] [Abstract][Full Text] [Related]
18. Successful immune tolerance induction in two boys with haemophilia B and inhibitory antibodies.
Klukowska A; Laguna P; Waleszkiewicz-Majewska B; Peregud-Pogorzelski J; Kamienska E; Bignell P; Giangrande P
Haemophilia; 2012 May; 18(3):e67-9. PubMed ID: 22531023
[No Abstract] [Full Text] [Related]
19. Failure of immunosuppression in a severe haemophilia B patient with specific antibody.
Allain JP; Frommel D
Thromb Haemost; 1976 Aug; 36(1):86-9. PubMed ID: 1036830
[TBL] [Abstract][Full Text] [Related]
20. Management of haemophilia B patients with inhibitors and anaphylaxis.
Warrier I
Haemophilia; 1998 Jul; 4(4):574-6. PubMed ID: 9873797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]